Comparison of partial amino acid sequences of two protamine 2 variants from stallion sperm. Structural evidence that the variants are products of different genes.

The research studied two variants of protamine 2 from stallion sperm, showing for the first time that the variants are produced from two different genes due to their differences in length and composition of amino acids.

Research Overview

• The researchers conducted a detailed study on protamine 1 and two variants of protamine 2, obtained from stallion sperm. Protamines are compact, arginine-rich nuclear proteins that replace histones late in the sperm cell development process and contribute to the degree of DNA compression.
• The separation of these three different proteins was achieved using acetic acid-urea gel electrophoresis, a technique widely used for separating proteins by their size and electric charge.

Protocol and Procedures

• After completing the separation process, the proteins were electroblotted onto polyvinyldifluoride filters. Electroblotting is used to permanently affix separated proteins or nucleic acids in a gel to a membrane.
• The researchers then determined the N-terminal (amino-terminal) amino acid sequences of the protamine variants using pulse-liquid peptide sequencing. This method is used for ordering the amino acids in a protein or a peptide, in this case, the protamines. The N-terminal refers to the start of a protein or polypeptide terminated by an amino acid with a free amine group.

Key Findings

• The research found that the sequences of the two protamine 2 variants are homologous but vary slightly in length and amino acid composition. The term “homologous” refers to having the same or similar relation, relative position, or structure, suggesting that the two variants are similar in structure but have some differences.
• This indicates for the first time that these two variants are products of two different genes for the protamine species. This is a significant discovery as it expands knowledge on the origins and genetic parameters of these protaminevariants.